Agilon Health, Inc.

Johnson Fistel Commences Investigation of Agilon Health, Inc.

Johnson Fistel, PLLP, a shareholder rights law firm, announces that it is investigating potential claims on behalf of investors of Agilon Health, Inc. (NYSE: AGL) regarding possible violations of federal securities laws.

For more information, contact James Baker at (619) 814-4471, jimb@johnsonfistel.com or fjohnson@johnsonfistel.com.

On August 4, 2025, Agilon Health, Inc. announced that its President, Chief Executive Officer, and Board Director, Steven Sell, had resigned from all positions. At the same time, the Company released its second-quarter 2025 financial results and withdrew its previously issued full-year 2025 earnings guidance. These disclosures came as a surprise to the market, and the Company’s share price fell by more than 27% in after-hours trading. The investigation focuses on whether Agilon failed to disclose information material to investors—specifically regarding the timing, circumstances, or implications of its leadership transition and guidance withdrawal—despite prior public statements, thereby potentially violating federal securities laws.

Oechsli Site Planner
Agilon Health, Inc. (ID: 13511) Featured Image:
  • Slug: agilon-health-inc-2
  • Word Count: 155
  • Post Statement:
  • Post Description:
  • Button: Read More
  • Button URL:
  • CTA:
Time to read: 1 minutes
  • rank_math_internal_links_processed: 1
  • rank_math_internal_links_processed: 1
  • rank_math_analytic_object_id: 1531
  • post_button: Read More
  • rank_math_seo_score: 7
  • formular_or_email: formular